已发表的部分文献: 标题:Epigenetic Silencing of DKK3 in Medulloblastoma.作者:Valdora F, Banelli B, Stigliani S, Pfister SM, Moretti S, Kool M, Remke M, Bai AH, Brigati C, Hielscher T, Romani M, Servidei T, Zollo M, Cinalli G, Oberthuer A, Tonini GP, Coco S;杂志名称:Int J Mol Sci 标题:Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity.作者:Kraus D, Yang Q, Kong D, Banks AS, Zhang L, Rodgers JT, Pirinen E, Pulinilkunnil TC, Gong F, Wang YC, Cen Y, Sauve AA, Asara JM, Peroni OD, Monia BP, Bhanot S, Alhonen L, Puigserver P, Kahn BB;杂志名称:Nature 标题:Aberrant Epigenetic Alterations of Glutathione-S-Transferase P1 in Age-Related Nuclear Cataract.作者:Chen J, Zhou J, Wu J, Zhang G, Kang L, Ben J, Wang Y, Qin B, Guan H;杂志名称:Curr Eye Res 标题:Epigenetic histone modulations of PPARγ and related pathways contribute to olanzapine-induced metabolic disorders.作者:Su Y, Liu X, Lian J, Deng C;杂志名称:Pharmacol Res Epigentek 公司是全球领先的表观遗传学相关研究的技术创新者和产品开发供应商。开发了超过700多个专利产品,为表观遗传学方面的研究和新药研发提供全面系统的解决方案,涵盖样品制备、DNA/RNA甲基化(5-mc, 5-hmc, 5-fc, m6A)/DNMT分析、ChIP、组蛋白甲基化/乙酰化/去乙酰化/磷酸化/SUMO-等领域,提供小分子抑制剂、蛋白质、抗体、以及分析试剂盒产品。